• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Movers For November 8, 2023

    11/8/23 4:30:08 PM ET
    $CARA
    $CRBP
    $GRWG
    $MXC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • EVIO (OTC:EVIO) shares closed up 4900.00% at $5e-05
    • Psychemedics (NASDAQ:PMD) shares closed up 27.63% at $2.91
    • 4Front Ventures (OTC:FFNTF) shares closed up 23.07% at $0.18
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 20.24% at $5.05
    • RIV Capital (OTC:CNPOF) shares closed up 12.50% at $0.09
    • Rocky Mountain High (OTC:RMHB) shares closed up 10.00% at $0.00
    • MedMen Enterprises (OTC:MMNFF) shares closed up 7.96% at $0.02
    • MJ Holdings (OTC:MJNE) shares closed up 7.27% at $0.02
    • Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 6.36% at $3.41
    • Rhinomed (OTC:RHNMF) shares closed up 4.35% at $0.02
    • Rivernorth Opps Fund (NYSE:RIV) shares closed up 3.84% at $10.82
    • C21 Investments (OTC:CXXIF) shares closed up 3.52% at $0.23
    • Green Thumb Industries (OTC:GTBIF) shares closed up 3.37% at $9.51
    • Trulieve Cannabis (OTC:TCNNF) shares closed up 3.16% at $4.90
    • Affinor Growers (OTC:RSSFF) shares closed up 3.07% at $0.01

    LOSERS:

    • Item 9 Labs (OTC:INLB) shares closed down 39.13% at $0.00
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 16.22% at $0.02
    • Kaya Holdings (OTC:KAYS) shares closed down 14.43% at $0.04
    • Auxly Cannabis Group (OTC:CBWTF) shares closed down 13.13% at $0.01
    • 22nd Century Group (NASDAQ:XXII) shares closed down 8.90% at $0.39
    • Zoned Props (OTC:ZDPY) shares closed down 7.83% at $0.47
    • Leafbuyer Techs (OTC:LBUY) shares closed down 7.27% at $0.05
    • Village Farms Intl (NASDAQ:VFF) shares closed down 6.84% at $0.72
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 6.45% at $1.16
    • Nextleaf Solutions (OTC:OILFF) shares closed down 6.04% at $0.04
    • BioHarvest Sciences (OTC:CNVCF) shares closed down 5.84% at $0.12
    • Target Group (OTC:CBDY) shares closed down 5.83% at $0.00
    • Body and Mind (OTC:BMMJ) shares closed down 5.41% at $0.07
    • Mexco Energy (AMEX:MXC) shares closed down 3.97% at $12.10
    • OrganiGram Holdings (NASDAQ:OGI) shares closed down 3.73% at $1.29
    • GrowGeneration (NASDAQ:GRWG) shares closed down 3.03% at $2.08

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CRBP
    $GRWG
    $MXC

    CompanyDatePrice TargetRatingAnalyst
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2025$28.00Buy
    B. Riley Securities
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    2/28/2025Outperform
    William Blair
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    12/2/2024Overweight
    Piper Sandler
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2024$85.00Outperform
    Wedbush
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/22/2024$80.00Buy
    H.C. Wainwright
    Organigram Global Inc.
    $OGI
    7/17/2024Speculative Buy
    Canaccord Genuity
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    6/26/2024$85.00Buy
    B. Riley Securities
    More analyst ratings

    $CARA
    $CRBP
    $GRWG
    $MXC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    B. Riley Securities resumed coverage on Corbus Pharma with a new price target

    B. Riley Securities resumed coverage of Corbus Pharma with a rating of Buy and set a new price target of $28.00

    7/30/25 8:22:15 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Corbus Pharma

    William Blair initiated coverage of Corbus Pharma with a rating of Outperform

    2/28/25 7:22:12 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GRWG
    $MXC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

    NORWOOD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and attend investor meetings at the 36th Annual Oppenheimer Healthcare Life Sciences Conference, to be held virtually February 25-25, 2026. 36th Annual Oppenheimer Healthcare Life Sciences Conference Format: Virtual presentation and one-on-one investor meetings Date: February 25, 2026 Presentation Time: 3:20pm Eastern TimeWebcast Link: Click Here About CorbusCorbus Pharmaceuticals Holdings, Inc. is a clinical stage oncolog

    2/12/26 8:00:00 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mexco Energy Corporation Reports Financial Results for Third Quarter

    MIDLAND, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE:MXC) today reported net income of $615,702, or $0.30 per diluted share, for the nine months ending December 31, 2025. For the third quarter of fiscal 2026, the Company reported net income of $50,245, or $0.02 per diluted share, a decrease of 89% when compared to $469,133, or $0.22 per diluted share, for the prior year quarter. This decrease is primarily due to the decline in oil prices. Operating revenues in the third quarter of fiscal 2026 were $1,383,887. For the nine months ended December 31, 2025, operating revenues were $4,932,806, a decrease of 8% when compared to the first nine months of fiscal 2025. Thi

    2/10/26 5:00:00 PM ET
    $MXC
    Oil & Gas Production
    Energy

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GRWG
    $MXC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Amendment: Chief Executive Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4/A - Village Farms International, Inc. (0001584549) (Issuer)

    6/3/25 9:00:14 PM ET
    $VFF

    Chief Financial Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:17:22 AM ET
    $VFF

    $CARA
    $CRBP
    $GRWG
    $MXC
    SEC Filings

    View All

    Mexco Energy Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - MEXCO ENERGY CORP (0000066418) (Filer)

    2/10/26 4:51:41 PM ET
    $MXC
    Oil & Gas Production
    Energy

    SEC Form 10-Q filed by Mexco Energy Corporation

    10-Q - MEXCO ENERGY CORP (0000066418) (Filer)

    2/10/26 4:49:47 PM ET
    $MXC
    Oil & Gas Production
    Energy

    Amendment: SEC Form SCHEDULE 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SCHEDULE 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    2/10/26 1:14:49 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GRWG
    $MXC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Smethurst Dominic sold $26,575 worth of shares (3,285 units at $8.09), decreasing direct ownership by 3% to 95,887 units (SEC Form 4)

    4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)

    2/4/26 4:25:42 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operating Officer Hodgson Ian sold $19,537 worth of shares (2,415 units at $8.09), decreasing direct ownership by 4% to 51,927 units (SEC Form 4)

    4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)

    2/4/26 4:24:39 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operating Officer Hodgson Ian was granted 28,365 shares, increasing direct ownership by 109% to 54,342 units (SEC Form 4)

    4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)

    1/16/26 4:30:03 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GRWG
    $MXC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GRWG
    $MXC
    Financials

    Live finance-specific insights

    View All

    Mexco Energy Corporation Reports Financial Results for Third Quarter

    MIDLAND, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE:MXC) today reported net income of $615,702, or $0.30 per diluted share, for the nine months ending December 31, 2025. For the third quarter of fiscal 2026, the Company reported net income of $50,245, or $0.02 per diluted share, a decrease of 89% when compared to $469,133, or $0.22 per diluted share, for the prior year quarter. This decrease is primarily due to the decline in oil prices. Operating revenues in the third quarter of fiscal 2026 were $1,383,887. For the nine months ended December 31, 2025, operating revenues were $4,932,806, a decrease of 8% when compared to the first nine months of fiscal 2025. Thi

    2/10/26 5:00:00 PM ET
    $MXC
    Oil & Gas Production
    Energy

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GRWG
    $MXC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    $CARA
    $CRBP
    $GRWG
    $MXC
    Leadership Updates

    Live Leadership Updates

    View All

    Village Farms International Creates Global Strategy Officer Role and Appoints Brian Stevenson

    Proven tobacco, pharmaceutical, and cannabis executive will lead the Company's enterprise-wide strategic agenda Appointment underscores the Company's commitment to disciplined global expansion and long-term value creation LAKE MARY, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF), today announced the appointment of Brian Stevenson to the role of Global Chief Strategy Officer. In this newly created role, Mr. Stevenson will lead the Company's enterprise-wide strategic agenda, including long-term growth strategy, global market assessment, and integration initiatives across regions and business units. Mr. Stevenson wil

    12/17/25 4:30:00 PM ET
    $VFF

    Organigram Announces Appointment of Chief Executive Officer

    Organigram Global Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of directors when he assumes the role of Chief Executive Officer. Mr. Yamanaka is a seasoned executive, having spent more than 20 years at British American Tobacco, with extensive experience in strategy and general management across

    11/25/25 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Village Farms Launches Promenade Brand's First Vape in Quebec

    HUNTINGDON, Quebec, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (NASDAQ:VFF), together with its Quebec-based subsidiary Rose LifeScience Inc., today announced the launch of Promenade's first vape product, Matin. This introduction marks a major step forward for Quebec's regulated cannabis market, as Promenade becomes one of the first brands to join the province's new vape category. While meaningful progress has been made in shifting consumers from the illicit to the legal market, the absence of a regulated vape category in Québec until now has limited consumer access to this format. An estimated 21 percent of Québec cannabis consumers previously turned to out-of-pro

    11/24/25 7:00:00 AM ET
    $VFF